According to Stryker Corporation's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.35912. At the end of 2022 the company had a P/S ratio of 4.27.
Year | P/S ratio | Change |
---|---|---|
2022 | 4.27 | -27.6% |
2021 | 5.90 | -8.1% |
2020 | 6.42 | 21.47% |
2019 | 5.28 | 22.42% |
2018 | 4.31 | -7.34% |
2017 | 4.66 | 17.55% |
2016 | 3.96 | 13.65% |
2015 | 3.49 | -5.43% |
2014 | 3.69 | 17.05% |
2013 | 3.15 | 30.84% |
2012 | 2.41 | 5.08% |
2011 | 2.29 | -20.18% |
2010 | 2.87 | -3.76% |
2009 | 2.98 | 24.17% |
2008 | 2.40 | -52.59% |
2007 | 5.06 | 21.77% |
2006 | 4.16 | 12.53% |
2005 | 3.70 | -18.89% |
2004 | 4.56 | -2.7% |
2003 | 4.68 | 5.7% |
2002 | 4.43 | 0.38% |
2001 | 4.41 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Medtronic MDT | 3.57 | -33.47% | ๐ฎ๐ช Ireland |
![]() Baxter BAX | 1.57 | -70.64% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | 5.23 | -2.36% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | 9.01 | 68.07% | ๐บ๐ธ USA |
![]() Waters Corporation WAT | 6.73 | 25.65% | ๐บ๐ธ USA |
![]() Integra LifeSciences IART | 3.11 | -42.02% | ๐บ๐ธ USA |
![]() Smith & Nephew
SNN | 2.66 | -50.32% | ๐ฌ๐ง UK |
![]() Owens & Minor
OMI | 0.1596 | -97.02% | ๐บ๐ธ USA |
![]() Hill-Rom HRC | N/A | -100.00% | ๐บ๐ธ USA |